Cargando…

Beta-adrenergic signaling, a novel target for cancer therapy?

Detalles Bibliográficos
Autor principal: Schuller, Hildegard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248132/
https://www.ncbi.nlm.nih.gov/pubmed/21317444
_version_ 1782220199605305344
author Schuller, Hildegard M.
author_facet Schuller, Hildegard M.
author_sort Schuller, Hildegard M.
collection PubMed
description
format Online
Article
Text
id pubmed-3248132
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-32481322012-01-18 Beta-adrenergic signaling, a novel target for cancer therapy? Schuller, Hildegard M. Oncotarget Commentaries Impact Journals LLC 2010-11-11 /pmc/articles/PMC3248132/ /pubmed/21317444 Text en Copyright: © 2010 Schuller http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
spellingShingle Commentaries
Schuller, Hildegard M.
Beta-adrenergic signaling, a novel target for cancer therapy?
title Beta-adrenergic signaling, a novel target for cancer therapy?
title_full Beta-adrenergic signaling, a novel target for cancer therapy?
title_fullStr Beta-adrenergic signaling, a novel target for cancer therapy?
title_full_unstemmed Beta-adrenergic signaling, a novel target for cancer therapy?
title_short Beta-adrenergic signaling, a novel target for cancer therapy?
title_sort beta-adrenergic signaling, a novel target for cancer therapy?
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248132/
https://www.ncbi.nlm.nih.gov/pubmed/21317444
work_keys_str_mv AT schullerhildegardm betaadrenergicsignalinganoveltargetforcancertherapy